thrombosis

synergy vs XIENCE

Diffuse Coronary Artery Disease: One-Year 48mm XIENCE Skypoint Outcomes

Long 48mm Stent XIENCE Skypoint in the treatment of diffuse CAD Long coronary artery lesions often involve complex decision making since they can be treated either with a long stent or with shorter overlapping stents. Both in registries and meta-analysis, the overlapping technique has been associated to increased target vessel revascularization and increased radioscopy time,<a href="https://solaci.org/en/2023/06/08/diffuse-coronary-artery-disease-one-year-48mm-xience-skypoint-outcomes/" title="Read more" >...</a>

TAVI: Balón expandible o autoexpandible ¿Cuál es la respuesta?

TAVR: Does HALT Affect Follow-Up?

Transcatheter aortic valve replacement (TAVR) in low-risk patients has been shown to be superior or noninferior in randomized studies, but the presence of valvular thrombosis, in its different forms, has not been well analyzed, nor is there much information on its impact on evolution. Researchers conducted an analysis of the LTR study that included 200<a href="https://solaci.org/en/2023/06/07/tavr-does-halt-affect-follow-up/" title="Read more" >...</a>

Resultado a 3 años luego de ATC con técnica de 2- stents vs Provisional stent por bifurcaciones complejas

Provisional Stenting vs. Culotte: 5-Year Results of EBC TWO

The optimal treatment of true bifurcation lesions not affecting the left main coronary artery is widely debated. Results from randomized studies have shown neutral or worse outcomes with the two-stent technique. Regarding these studies, researchers used first-generation stents and the secondary branches were small. The EBC TWO study compared the provisional stenting strategy against the<a href="https://solaci.org/en/2023/05/29/provisional-stenting-vs-culotte-5-year-results-of-ebc-two/" title="Read more" >...</a>

EuroPCR 2023 | ACURATE Neo2: Results After 5 Years

The ACURATE Neo2 valve is an evolution of the first-generation ACURATE Neo valve with a low rate of pacemaker implantation and a decrease in paravalvular leak, also compatible with the 14F introducer. This prospective study included patients with symptomatic severe aortic stenosis at high surgical risk who underwent ACURATE Neo2 valve implantation. The primary endpoint<a href="https://solaci.org/en/2023/05/23/europcr-2023-acurate-neo2-results-after-5-years/" title="Read more" >...</a>

EuroPCR 2023 | Intravascular Lithotripsy (IVL) Balloon in the Treatment of Underexpanded Stents

Calcified coronary plaque (CCP) is a challenge for interventional cardiology. Stent underexpansion (SU) commonly associated with CCP could predispose to stent thrombosis or restenosis. Currently, SU in severe CCP can be treated by rotational atherectomy, orbital atherectomy, balloon cutting/scoring, non-compliant high-pressure balloons, or intravascular lithotripsy (IVL). The aim of this meta-analysis was to determine the<a href="https://solaci.org/en/2023/05/22/europcr-2023-intravascular-lithotripsy-ivl-balloon-in-the-treatment-of-underexpanded-stents/" title="Read more" >...</a>

EuroPCR 2023 |Chimney Stenting vs BASILICA for the Prevention of Coronary Obstruction during TAVR

Coronary obstruction is a complication from TAVR that can cause death (up to 50% mortality), even though its incidence is lower than 1%.&nbsp; One of the most frequent strategies used in the prevention of this complication is chimney stenting in patients at high anatomical risk (valve in valve, narrow sinotubular junction, short coronary ostium height).<a href="https://solaci.org/en/2023/05/17/europcr-2023-chimney-stenting-vs-basilica-for-the-prevention-of-coronary-obstruction-during-tavr/" title="Read more" >...</a>

EuroPCR 2023 | EBC Two – Provisional Stenting vs Culotte in Bifurcations

MD Sandeep Arunothayaraj presented the 5-year followup of EBC Two (which had not previously shown significant differences in clinical outcomes at 12 months) in patients randomized to provisional stenting vs. systematic culotte in bifurcations that were not left main.&nbsp; The study followed up 200 patients with true bifurcations, side branch ≥2.5mm and lesion length ≥5mm,<a href="https://solaci.org/en/2023/05/17/europcr-2023-ebc-two-provisional-stenting-vs-culotte-in-bifurcations/" title="Read more" >...</a>

Abbreviated Antiaggregant Treatment in High Bleeding Risk Patients from the MASTER-DAPT (15-Month Followup)

Benefits of abbreviated antiaggregant treatment in high bleeding risk patients.&nbsp; Dual antiplatelet therapy (DAPT), established by different guidelines, reduces the risk of ischemic events at the expense of increased bleeding. This habitual APT strategy cannot be applied to patients at high risk of bleeding, which is why this populations are treated with shorter DAPT schemes<a href="https://solaci.org/en/2023/05/15/abbreviated-antiaggregant-treatment-in-high-bleeding-risk-patients-from-the-master-dapt-15-month-followup/" title="Read more" >...</a>

TAVI bajo riesgo

Evolute Low Risk at 3 Years: Promising Outcomes

Transcatheter aortic valve replacement has shown important benefits but one of its biggest challenges is showing its safety and efficacy at followup in low risk patients. At present we have 2-year data from the Evolute Low Risk, but the we lack information at longer followup.&nbsp; The study looked at 3-year followup of the Evolute Low<a href="https://solaci.org/en/2023/05/03/evolute-low-risk-at-3-years-promising-outcomes/" title="Read more" >...</a>

Un guiño para la trombólisis guiada por Catéter en tromboembolismo pulmonar

CLOUT Registry: Thrombectomy in TVP with ClotTriever

Safety and efficacy of the ClotTriever device in extended deep vein thrombosis.&nbsp; The endovascular treatment of thromboembolic disease has evolved and new devices have come out in the last few years to reduce morbimortality from its complications. Sub-treating this pathology has long term implications, such as reduced quality of life, limiting functional class and, worst<a href="https://solaci.org/en/2023/05/03/clout-registry-thrombectomy-in-tvp-with-clottriever/" title="Read more" >...</a>

Top